Tag: Beau Noafshar

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.

Pharma Space Facing Challenges Due to Uncertain Policies

Fitch pharma and healthcare analyst Beau Noafshar said decision making will be supported by a robust global economy in 2020.